Medipharm Labs Continues To Advance Its Domestic Cannabis Business While Staying Laser Focused On International Expansion

During the last year, we have noticed a substantial increase in demand for cannabis concentrates and this comes after Canada legalized cannabis derivative products in late 2019. The change in the types of products that are available is referred to as Canada’s cannabis 2.0 market and we are favorable on companies that are capitalizing on this vertical.

MediPharm Labs Corp. (TSX: LABS) (OTCQX: MEDIF) (FSE: MLZ) has been a beneficiary of Canada’s cannabis 2.0 market and we consider it to be a leading play on the global cannabis concentrate market. The company is focused on capturing additional market share in Canada’s medical and recreational cannabis market as well as emerging international markets and we are favorable on the direction the business is heading.

A Canadian Expansion Story to be Aware of

In Canada, the specialized cannabis extraction company has been executing on a multi-faceted growth strategy and we are favorable on the direction the business is heading. Earlier this week, MediPharm Labs reported to have entered into a supply agreement in Quebec. In addition to Quebec, the company’s private and white-label cannabis products are available in 6 other provinces (Ontario, Nova Scotia, Alberta, British Columbia, Manitoba, and Saskatchewan) and expect its products to be available in additional provinces later this year.

MediPharm cannabis products will be for sale in Quebec’s recreational market through provincial-owned retail outlets and an e-commerce platform. We are bullish on the growth prospects that are associated with the Quebec market and expect it to serve as a major revenue generator for the business.

With the agreement with Quebec, MediPharm is delivering its premium proprietary cannabis derivative products to 95% of the retail market in Canada. In Quebec, the amount of product that is needed will be determined on a month-over-month basis and we will monitor how MediPharm’s products gain traction with consumers.

1 2 3 4
View single page >> |
How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.